Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
New research shows that 65% of people in the US will be partially vaccinated by July 4 — but for Hispanic and Black people, rates are lower.
With COVID-19 information evolving daily, the Stanford Health Care pharmacy team had to prepare for the unexpected in its vaccine rollout.
Induced pluripotent stem cells share proteins with some cancers. The cells can be used as a vaccine to prevent pancreatic cancers in mice.
Staff and faculty from across Stanford Medicine are stepping up to vaccinate members of the community at sites across the Bay Area.
Health educator’s widely praised and popular videos draw on humor and creativity to spread a COVID-prevention message to a global audience.
Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.
This Voices of COVID piece features Charles Ayson, an experienced night-shift nurse on a COVID-19 unit, who is helping his team of nurses navigate the pandemic.
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.